Ionotropic Receptor Antibodies

Ace Therapeutics is committed to supplying high-quality ionotropic receptor antibodies for stroke research to our clients at cost-effective prices. At Ace Therapeutics, we understand the critical role of ionotropic receptor antibodies in stroke research. We aim to offer cost-effective solutions to ensure that our clients can access the antibodies they need without compromising on quality.

Ionotropic receptors are protein receptors located on cell membranes that trigger intracellular signaling pathways by binding to specific ions. Studies have shown that dysfunction of certain ionotropic receptors is associated with an increased risk of stroke. For example, dysfunction of the N-methyl-D-aspartate receptor (NMDAR) is associated with the development and progression of stroke. NMDA receptor is a calcium ion channel that regulates excitability, learning, and memory in neurons. Studies have found that abnormal NMDA receptor function may lead to neuronal damage and changes in pathogenesis, thereby being associated with the occurrence and progression of stroke.

Please access our all-series ionotropic receptor antibodies or contact our scientist for personalized assistance.